These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Urothelial carcinoma with plasmocytoid component. Kourda N; Bouzouita A; Azouz H; Derouiche A; Blel A; Chebil M; Ben Jilani SB; Zermani R Pathologica; 2009 Dec; 101(6):253-4. PubMed ID: 20387714 [TBL] [Abstract][Full Text] [Related]
23. Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Liu T; Niu Y; Feng Y; Niu R; Yu Y; Lv A; Yang Y Hum Pathol; 2008 Nov; 39(11):1637-46. PubMed ID: 18657295 [TBL] [Abstract][Full Text] [Related]
24. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification. Kalantari MR; Ahmadnia H Urol J; 2007; 4(4):230-3. PubMed ID: 18270948 [TBL] [Abstract][Full Text] [Related]
25. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N Urol J; 2009; 6(2):101-8. PubMed ID: 19472128 [TBL] [Abstract][Full Text] [Related]
26. Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study. Gourlay W; Chan V; Gilks CB Mod Pathol; 1995 May; 8(4):394-7. PubMed ID: 7567937 [TBL] [Abstract][Full Text] [Related]
27. Expression of cytokeratin 20 in urine cytology smears: a potential marker for the detection of urothelial carcinoma. Bhatia A; Dey P; Kumar Y; Gautam U; Kakkar N; Srinivasan R; Nijhawan R Cytopathology; 2007 Apr; 18(2):84-6. PubMed ID: 17397492 [TBL] [Abstract][Full Text] [Related]
28. P16, c-erbB2 and Ki67 immunoexpression in urothelial carcinomas of the bladder. Stepan A; Simionescu C; Mărgăritescu C; Ciurea R Rom J Morphol Embryol; 2011; 52(2):653-8. PubMed ID: 21655657 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma. Swellam M; El-Arab LR; Adly A Clin Biochem; 2008 Sep; 41(13):1059-66. PubMed ID: 18602381 [TBL] [Abstract][Full Text] [Related]
30. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue. Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954 [TBL] [Abstract][Full Text] [Related]
31. Transition of cervical carcinoma in situ to invasive cancer: role of p16 INK4a expression in progression and in recurrence. Anschau F; Schmitt VM; Lambert AP; Gonçalves MA; Machado DC Exp Mol Pathol; 2009 Feb; 86(1):46-50. PubMed ID: 19100258 [TBL] [Abstract][Full Text] [Related]
32. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases. Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786 [TBL] [Abstract][Full Text] [Related]
33. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Kanellou P; Zaravinos A; Zioga M; Spandidos DA Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278 [TBL] [Abstract][Full Text] [Related]
34. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma. Loy TS; Alexander CJ; Calaluce RD Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688 [TBL] [Abstract][Full Text] [Related]
35. [Correlation of p16/INK4a gene damages and protein expression in the tumor tissue of sporadic breast cancer]. Nemtsova MV; Zemliakova VV; Kuznetsova EV; Popova OP; Zavalishina LE; Frank GA; Zaletaev DV Arkh Patol; 2008; 70(4):6-9. PubMed ID: 18807517 [TBL] [Abstract][Full Text] [Related]
36. [Expression of p16INK4a in various cancer cells]. Volgareva GM; Zavalishina LE; Andreeva IuIu; Frank GA; Golovina DA; Spitkovskiĭ DD Arkh Patol; 2004; 66(5):3-5. PubMed ID: 15575375 [TBL] [Abstract][Full Text] [Related]
37. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study. Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755 [TBL] [Abstract][Full Text] [Related]
38. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404 [TBL] [Abstract][Full Text] [Related]
39. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577 [TBL] [Abstract][Full Text] [Related]